510(k) K161817
K161817 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Operations (Rdo) for the device "Tina-quant Cystatin C Gen.2". The FDA issued a decision of Substantially Equivalent on Jul 27, 2016. The device falls under product code NDY (Test, Cystatin C), a Class II device regulated under 21 CFR 862.1225. Roche Diagnostics Operations (Rdo) has 13 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 27, 2016
- Date Received
- Jul 1, 2016
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Test, Cystatin C
- Device Class
- Class II
- Regulation Number
- 862.1225
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for Roche Diagnostics Operations (Rdo)? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.